The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Sep 2007 07:00

Cubus Lux plc (the "Company") Director/PDMR Shareholding

Cubus Lux plc announces that, pursuant to the exercise of a share option agreement dated 7 June 2004, it has allotted 210,000 ordinary shares of 1p each in the Company for a consideration of 1p each to Eli Abramovich, a director of the Company, conditional on the admission of these shares to trading on AIM. Application has been made for the 210,000 shares to be admitted to AIM, which is expected to become effective on 26 September 2007.

Following the above allotments, Mr Abramovich has an interest in 240,000 ordinary shares in the Company, representing 0.25 per cent. of the Company's total voting rights. Mr Abramovich also has 1,000,000 share options, which were issued on 27 April 2006, exercisable at a price of 10p and expiring on 26 April 2011.

The 30,000 ordinary shares of 1p each in the Company in which Mr Abramovich held an interest prior to the exercise of options described above were acquired on 30 November 2006 at a price of 19p, which purchase was not notified to the market as a result of an error by the Company.

Following the issue of equity described above, the enlarged issued share capital of the Company comprises 97,662,518 ordinary shares of 1p each.

The option agreement referred to above was granted on 7 June 2004, and provided that the shares would vest in three equal tranches over three years, the last of which on 7 June 2007. It also provided that the option would immediately cease to be exercisable if not exercised in full by midnight on 7 June 2007. In March 2007, the board of the Company extended the exercise period of this option by three months as it believed that 7 June 2007 fell during a close period which would preclude the exercise of the option. Mr Abramovich wrote to the board in August 2007 to confirm his intention to exercise the option and the board met on 20 September 2007 to approve the exercise and the allotment of these shares.

For further information please visit at www.cubuslux.com or contact:

Steve McCannCubus Lux plc+385 (0)99 214 9636Simon Sacerdoti/Liam MurrayCity Financial Associates Limited+44 (0)20 7492 4777Graham Herring/Josh RoystonThreadneedle Communications Limited+44 (0)20 7936 9605

CUBUS LUX PLC
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.